Clinical Trial Update: Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating intravesical Bacillus Calmette-Guérin (BCG) and alternative BCG protocols for intermediate and high-risk non-muscle invasiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (BCG) vaccine (Bacillus Calmette-Guérin vaccine)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Urinary Bladder Neoplasms, BCG Vaccine | Phase 3 | Status: RECRUITING